chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report was received from a registered nurse refers to a patient of unknown age and gender. The patient was vaccinated with expired dose 2 GARDASIL (lot # 666121/1778Y) expiration date 19-AUG-2012) (dose and route not reported) on 28-SEP-2012. No concomitant medications were reported. The patient was not experiencing any known symptoms. No further information is available. Additional information has been requested.
SEVERE hot flashes for four days after receiving my Covid booster (3rd shot). They were so intense and frequent at night that I couldn't sleep at all. Worst on 2nd & 3rd days after injection, about 20x per night, lasting 5-10 min each. They happened during the day too, but the nighttime interference with my sleep for consecutive nights was terrible!  (Note: I am post-menopausal for over 10 yrs)
have a patient who got 3 doses of Shingrix; This case was reported by a other health professional via(Shingrix Chatbot) interactive digital media and described the occurrence of extra dose administered in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on an unknown date) and Shingrix (2nd dose received on an unknown date).   On an unknown date, the patient received the 3rd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced extra dose administered. On an unknown date, the outcome of the extra dose administered was unknown.  Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that, the patient received 3 doses of Shingrix, which led to extra dose administered.
ANTHRAX BOOSTER (SHOT #9 IN THE SERIES) ON 23 MAY 2007. ON THE AFTERNOON OF 24 MAY, PT COMPLAINED OF A LARGE DARK PURPLE AREA, AND BIG LUMP AT THE INJECTION SITE. ON 31 MAY 07, PT WAS SEEN BY PCM FOR EVALUATION. PT STATES THAT PCM READ THE ANTHRAX VIS AND CONCLUDED THAT THIS WAS A MODERATE REACTION AND COMPLETE A VAERS FORM. PT WAS PRESCRIBED TYLENOL.
Patient had flu shot yesterday (11/8/17) - today (11/9/17) whole upper arm lateral aspect turned red from deltoid area to elbow bright red with mild swelling - mildly tender - no fever - no Hx of past RXN like this; Imp Intense local RXN to flu vaccination; instructed to use MOTRIN and ice pack.  MD advised patient to return for follow-up should condition worsen.
PAIN, REDNESS, AND SWELLING OF LEFT ARM THAT DEVELOPED INTO CELLULITIS.
Rah on lower right arm with redness and intense itching from elbow to wrist. Told her to try BENADRYL for 1-2 days and see MD if doesn't resolve.
I am having a severe racing heartbeat rasping; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported.  The following information was reported: HEART RATE INCREASED (non-serious), outcome "unknown", described as "I am having a severe racing heartbeat rasping". Relevant laboratory tests and procedures are available in the appropriate section.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
30 minutes after injection I felt tenderness in lymph nodes below my ears and then my face became totally numb. I mostly felt the numbness in the sides of my face and chin. This lasted for approx 1 hour and did not return. I didn?t notice swelling.
pt experienced- shakiness, syncope, clammy. B/P 133/81, O2 100%, HR 69. 50 mg IM Benadryl given.
Arm was sore at the injection site, as the day worn on it became extremely painful to the point where I couldn't lift my arm.  During the night I woke up shivering and my entire body ached.  I could hardly sleep.  I could not go to work the day after the injection.  I felt aching and tired through the afternoon and my arm still ached.  By evening I felt much better. The following day I was able to return to work and normal activities with still a bit of pain in my arm
Over a week ago I started feeling a tightness in my right cheek and neck. I wasn't sure what it was but it went away. I received my second vaccination 3 days ago and the tightness is back. Accompanied by sore throat. I felt the area and the lymph node in front of my right ear and the one in my neck on ther right side are swollen. :
I still got sick no matter cause I'm fully vaccinated; I still got sick no matter cause I'm fully vaccinated; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP), Program ID: (175705). The reporter is the patient.  A 54-year-old male patient received BNT162b2 (COMIRNATY), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "I still got sick no matter cause I'm fully vaccinated".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
24hr p/vax presented to ER w/5x3cm area of induration;no erythema/ecchymosis/fluctuance/tenderness-using legs symmetrically-med given, warm compresses;17JUN95 1 1/2 x 3cm area of redness;2cm area of firmness underlying this;
Reddened area, tender to touch, increase in warmth at vaccine site back of right arm to elbow. Area marked. No increase since initial vaccine.
Information has been received from a consumer concerning her 8 year old daughter with no allergies or medical history who on 15-MAR-2002 was vaccinated with a dose of Varivax. There was no concomitant medication. On 30-JAN-2007, the patient developed a breakthrough case of chickenpox. The lesions were red with a white center. There were approximately 20 lesions. The reporter stated that she probably would not take her daughter to the physician's office. Unspecified medical attention was sought. No diagnostic laboratory tests were performed. At the time of the report, the patient had not recovered. A product quality complaint was not involved. Additional information has been requested.
Narrative: Patient received COVID 19 vaccine at outside facility per note on 21 May 2021. The patient tested positive for COVID 19 on 18 July 2021 and was admitted to the hospital on 22 July 21. The patient was treated and then discharged on 3 August 2021. Per EUA patients that tested positive for COVID 19 and were hospitalized after receiving the vaccine must be reported.
fever up to 104 onset 5AUG95 lasted til 7AUG95; rash onest 6AUG completely gone 9AUG flat pin small spots ran together, anorexic, vomited 1x Saturday 5AUG;
Patient had second vaccine on 4/29/21. He started having fatigue, body aches, headache, chest pressure, nausea and shortness of breath on 4/30/29 that continued through 5/2/21. He started feeling somewhat better the night of 5/2/21. Symptoms have resolved today.
Abnormal eye movements noticed by mother of patient on 9-30-13 - was seen in ER. MRI was normal. 6th cranial nerve damage (strabismus) - normal MRI, referred to ophthalmologist.
They had a bad rash, but it does not hurt. It is swollen, itchy and red; They had a bad rash, but it does not hurt. It is swollen, itchy and red; They had a bad rash, but it does not hurt. It is swollen, itchy and red; This spontaneous case was reported by a patient and describes the occurrence of SWELLING (They had a bad rash, but it does not hurt. It is swollen, itchy and red), RASH PRURITIC (They had a bad rash, but it does not hurt. It is swollen, itchy and red) and RASH ERYTHEMATOUS (They had a bad rash, but it does not hurt. It is swollen, itchy and red) in a 58-year-old female patient who received mRNA-1273.815 (SPIKEVAX 2023-2024) for COVID-19 prophylaxis.     The patient's past medical history included COVID-19 on 25-Aug-2020. Previously administered products included for Product used for unknown indication: Flu shot (27 or 28-SEP-2023) in September 2023. Past adverse reactions to the above products included No adverse event with Flu shot.    On 04-Nov-2023, the patient received sixth dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (unknown route) 1 dosage form. On an unknown date, the patient experienced SWELLING (They had a bad rash, but it does not hurt. It is swollen, itchy and red), RASH PRURITIC (They had a bad rash, but it does not hurt. It is swollen, itchy and red) and RASH ERYTHEMATOUS (They had a bad rash, but it does not hurt. It is swollen, itchy and red). At the time of the report, SWELLING (They had a bad rash, but it does not hurt. It is swollen, itchy and red), RASH PRURITIC (They had a bad rash, but it does not hurt. It is swollen, itchy and red) and RASH ERYTHEMATOUS (They had a bad rash, but it does not hurt. It is swollen, itchy and red) had not resolved.        For mRNA-1273.815 (SPIKEVAX 2023-2024) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not reported.  The patient received first dose on 29-Jan-2021 and the lot number 0303L20A. Second dose received on 26-Feb-2021 and the lot number 0303L20A. Third dose received on 22-Oct-2021 (Booster) and the lot number 084G21A. Fourth dose received on 09-Apr-2022 and the lot number Unknown. Fifth dose received on 03-Oct-2022 and the lot number 027E22A. No treatment information was provided by the reporter.
Within 4 hours my arm was red and tender. I slept for 35 hours out of the next 42 hours, I was out and did not even get up, maybe only woke up to turn my head. My arm got bigger and the redness spread and it went above my shoulder, probably 4 cm below my antecubital and wrapped around the entire arm. It was increasing for 3 days. I had a temperature of 103 for those 4 days so I took it the first time on 03/18/21, I felt hot, I had a fever, didn't take it until the next day. I called the doctor, they wouldn't see me because of the fever and COVID-19, so they did a telehealth visit. It was difficult for the doctor to look at my arm and it was two times the size of my other arm and flaming hot to the touch and hard like I was tapping on a wood tabletop. He put me on an antibiotic for the cellulitis in my arm. I missed work Thursday through Sunday. On Monday when I went back to work I felt terrible, Tuesday I worked a short day, Wednesday was also a short day, that night I still had fever, I wasn't eating or drinking and very dehydrated. I went to bed 03/25/21 but didn't go to sleep and got up vomiting so much with such strength until I was dry heaving. I had a lot of abdominal pain and knew I needed to go to the ER but I didn't want to bother my neighbors with ambulance lights. I went to the ER the next day and was diagnosed with gallstones, at first they thought it was a UTI but cultures came back fine except the urine. They put me on antibiotics and antifungals and planned to do surgery on 03/27/21. My gallbladder was gangrenous, I've never had symptoms of that. I was in the hospital, was discharged on Sunday morning and I was off of work until the first of May. I saw the surgeon sometimes afterwards and they considered it a slow recovery because I was still sleeping hours a day and I'd be in a chair just sitting and then wake up three hours later. I was sleeping 18 hours a day everyday post coming home. All of a sudden went away Easter night, 03/29/21 I had an appointment scheduled to see PCP for the cellulitis and instead he mostly talked about post-op. The swelling went down but when I was hospitalized I had that arm with an IV and I was never dependent so much on it so it was much less swelling at my follow up and the discoloration and darkening part stayed for two months.
Patient said the pain lasted 3 to 4 days and she could barely move her arm.
About a week after the first shot my teeth felt like electrical sensations  and sensitive. Two days after the 2nd shot back of mouth on left side (same side as the shot) I had pain and sensations. After a few days I went to the dentist to  make sure I didn?t crack a tooth etc. They said my teeth were fine. They photographed a sore and the dentist said she had seen another lady with many of the same sores and they looked like someone who had covid/had the vaccine
Information has been received from a physician concerning a 72 year old female who "within the last six months," in approximately 2007, was vaccinated with a dose of Zostavax. It was noted that she was vaccinated at "alternate vaccination sites." Subsequently, in approximately 2007, the patient developed shingles. Additional information has been received from the physician who reported that the patient complained of a herpes zoster outbreak post-vaccination. She was noted to have had experienced shingles prior to vaccination as well. She recovered on an unspecified date. No further information is expected.
Patient stop by to pharmacy to let us know that she had slight irritated skin at the site of injection.
vaccinated and still had whooping cough/ suspected vaccination failure; whooping cough; This case was reported by a consumer via (Facebook) interactive digital media and described the occurrence of suspected vaccination failure in an unspecified number of patients who received DTPa (DTaP vaccine) for prophylaxis.   On an unknown date, the patient received DTaP vaccine. On an unknown date, unknown after receiving DTaP vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and whooping cough (serious criteria GSK medically significant). On an unknown date, the outcome of the vaccination failure and whooping cough were unknown.   It was unknown if the reporter considered the vaccination failure and whooping cough to be related to DTaP vaccine.  Additional details were provided as follows: This case was reported by the parents for their kids. The age at vaccination was not applicable for this report. The reporter stated that they recommend the tetanus shot every 10 years due to infections. Unfortunately, that tetanus vaccine has the other stuff in it too (Diphtheria and pertussis). The patients were vaccinated and still had whooping cough.  The reporter stated not every shot works. This case was considered to be a suspected vaccination failure case, as the details regarding completion of primary vaccination schedule, laboratory confirmation for whooping cough and time to onset were unknown. This case has been linked with the case US2021AMR215942, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR215942:same reporter
Pt given shot at 3:30 PM 11-18-09.  Pt reported vomiting at approx 1:00 AM the next morning & was seen at 11: AM at doctor's office 11-19-09.  Spiked 101.2 fever 11-19-09 and that broke before midnight.  Phone call to mother at noon 11-20-09 pt is well.
Initial unsolicited literature report received from a physician on 16 June 2015. This case is linked to 2015SA092506, 2015SA092507, 2015SA092508, 2015SA092509, 2015SA092510, 2015SA092511, 2015SA092512, 2015SA089479, 2015SA092722, 2015SA092723, 2015SA092724 (same vaccine). Abstracts: Objective: To evaluate pregnancy outcomes of women who received Tdap vaccination at or after 32 weeks of gestation. Outcomes from consecutive pregnancies during which the mother received Tdap were also analyzed. Methods: In a retrospective cohort study at a single institution, we compared pregnancy outcomes between those who accepted or declined Tdap at 32 weeks of gestation. Additionally, women who received Tdap vaccination in this and a prior pregnancy in the past 5 years were compared with multiparous women who only received Tdap in this pregnancy. Results: Since 2013, 7,378 women who were offered the Tdap vaccine antenatally delivery at our institution: 7,152 accepted (97 percentage). There was no difference in stillbirths, major malformations, chorioamnionitis, 5-minute Apgar score, or cord blood pH. Neonatal complications including ventilation requirement, sepsis, intraventricular hemorrhage, and neonatal death were also similar. However, preterm birth rates at 36 weeks of gestation or less (6 percentage compared with 12 percentage, P less than 0.001), incidence of small for gestational age (10 percentage compare with 15 percentage, P equal to 03), and length of neonatal hospitalization (3.9 compared with 4.7 days, P less than 001) were all significantly increased in the unvaccinated cohort. No difference in neonatal outcomes was noted between women who were administered at lest two Tdap vaccines in the past 5 years (n equal to 1,229) and those who received only a single dose (n equal to 4,159). Conclusion: No adverse pregnancy outcomes were identified in association with antepartum Tdap vaccination. This remained true in women receiving more than one Tdap vaccine in a 5-year timeframe. This may be the result of a type II error. A 7,378 number of female patients out of which (97 percentage) patients received Tdap vaccine and 226 (3 percentage) patients declined Tdap vaccine. A 7,152 number of female patients, whose medical history and concomitant medication were not reported had received a dose of Tdap (batch number, expiration date, dose, dose number, route and site of administration were not reported) on an unspecified date. As Tdap vaccine was exposure in utero, thus 526 numbers of neonate patients out of which 99 (1 percentage) patients gestational age at delivery was 34 or less weeks and 427 (6 percentage) patients gestational age at delivery was 36 or less weeks. Laboratory investigation and corrective treatment were not reported. At the time of this report, the outcome of the event was unknown. Documents held by sender: none.
Received immun. 3 days ago- yest. started swelling and redness with fever 101 degrees
Patient was given the vaccine 27 days after the beyond use date. Patient denies adverse effects.
There were no adverse reactions; patient received improperly stored vaccine; This spontaneous report as received from a medical assistant refers to an 18-month-old male patient. Pertinent medical history, drug reactions, allergies and concomitant medications were not reported.  On 29-APR-2019, the patient was vaccinated with the improperly stored dose of hepatitis a vaccine, inactivated (VAQTA) injection (lot number: S002460, expiration date: 15-MAY-2020; dose was not reported) administered intramuscularly. The vaccine was stored in temperature 52.5 degrees Fahrenheit for 4 hours and 40 minutes. There was no previous temperature excursion. Digital data lodger was involved.  There were no adverse reactions.
IN 1971 I WAS GIVEN SMALLPOX VACCINE. I BEGAN PASSING OUT AND GETTING SHORT OF BREATH WITH CHEST PAINS. THEY SENT ME TO A HOSPITAL. THE CARDIOGLIST RECOMMENDED DISCHARGE. ALL MY MEDICAL RECORDS HAVE DISAPPEARED AS THIS WAS A TEST VACCINE I HAVE SUFFERED THE SIDE AFFECTS ALL THE REST OF MY LIFE. I HAVE HEARD NEWS REPORTS ABOUT THIS SAME VACCINE WITH SAME SYMPTOMS AND DONT WANT MORE PEOPLE TO SUFFER LIKE ME. Per 60 follow up: I have fluid around my heart, I take 3 blood pressure medications 3 times a day, I have not had a day go by since I got this shot that I haven't had some bad reactions from migraines to fluid in my chest and pain. The VA refuses to admit that I received this vaccine at anytime in the marine corps so I plan to get an attorney to sue to recover for my pain and suffering.  1/4/10 I still have migraine headaches and fibromiagama. I also have fluid around my heart and take over 6 blood pressure pills including fluid pills a day. I also take four pensation pain pills a day. I have these problems since the day I was give this vaccine.
A day after vaccine, felt feverish & tired. 36 hrs after hospitalized. Patient said fluid in her lungs could be pneumonia.
Cough; itchiness; throat irritation; Headache; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Cough), PRURITUS (itchiness), THROAT IRRITATION (throat irritation) and HEADACHE (Headache) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) for an unknown indication.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced COUGH (Cough), PRURITUS (itchiness), THROAT IRRITATION (throat irritation) and HEADACHE (Headache). At the time of the report, COUGH (Cough), PRURITUS (itchiness), THROAT IRRITATION (throat irritation) and HEADACHE (Headache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
New onset seizures, approximately 5 hours after receiving COVID vaccine. (2 seizures)  Family heard a shout and a thump and arrived to find him actively seizing. Family called 911.  He does have a history of hitting his own head with his hands when he is frustrated but no banging on hard surfaces and no increase lately.  No recent hx of trauma, fever, cough, runny nose, diarrhea.  It is also possible that he has had an adolescent onset of epilepsy.  Seizures are more common in children with autism. He may have had a lower seizure threshold and the vaccine inflammation may have exceeded it.  It is unlikely that he has an intracranial event with normal behavior (for him) between seizures and a normal neuro exam.
1st dose 01/29/2021; 2nd dose 02/19/2021 - diagnosed with COVID 19 4/22/21
Pt developed redness around injection site, pt was also given 1 oral dose of Benadryl. Pt waited 30 mins & was okay to go home (right thigh).
Diagnosed with rhabdomyolysis; Found on floor with knee in an awkward position; Strength has not come back in legs and now needs a walker; Did not have strength to lift legs to go to bed; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of RHABDOMYOLYSIS (Diagnosed with rhabdomyolysis) and JOINT DISLOCATION (Found on floor with knee in an awkward position) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026A21A and 032L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Cholesterol. Concomitant products included LEVOTHYROXINE and ROSUVASTATIN for an unknown indication.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 11-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced ASTHENIA (Did not have strength to lift legs to go to bed). On 12-Mar-2021, the patient experienced RHABDOMYOLYSIS (Diagnosed with rhabdomyolysis) (seriousness criteria hospitalization and medically significant), JOINT DISLOCATION (Found on floor with knee in an awkward position) (seriousness criterion hospitalization) and GAIT DISTURBANCE (Strength has not come back in legs and now needs a walker). The patient was hospitalized from 12-Mar-2021 to 18-Mar-2021 due to JOINT DISLOCATION and RHABDOMYOLYSIS. At the time of the report, RHABDOMYOLYSIS (Diagnosed with rhabdomyolysis), JOINT DISLOCATION (Found on floor with knee in an awkward position) and ASTHENIA (Did not have strength to lift legs to go to bed) outcome was unknown and GAIT DISTURBANCE (Strength has not come back in legs and now needs a walker) had not resolved.            Treatment for events included  fluids and shots in knee.  The patient received both scheduled doses of mRNA-1273 prior to the events; therefore, action taken with the drug in response to the events is not applicable.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.